{"id":"W4389752878","doi":"10.1016/s2468-1253(23)00318-7","title":"Efficacy and safety of 48 weeks of guselkumab for patients with Crohn's disease: maintenance results from the phase 2, randomised, double-blind GALAXI-1 trial","year":2023,"lang":"en","type":"article","venue":"˜The œLancet. Gastroenterology & hepatology","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":70,"is_retracted":false,"has_abstract":false,"ca_institutions":"Western University; University of Calgary","funders":"Janssen Scientific Affairs; Genentech; Celgene; Amgen; Pfizer; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Crohn's disease; Medicine; Disease; Internal medicine; Phase (matter); Double blind; Maintenance therapy; Physical therapy; Surgery; Pediatrics; Alternative medicine; Placebo; Pathology; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006338489,0.0003119739,0.0007047679,0.0000602202,0.0001616709,0.00001266854,0.0005910415,0.0001832257,0.0000100216],"category_scores_gemma":[0.0002719358,0.0001984679,0.0001942938,0.00009621869,0.0009672706,0.00000910888,0.0002336179,0.0001877883,0.000003774124],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001477465,"about_ca_system_score_gemma":0.0001293574,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002608174,"about_ca_topic_score_gemma":0.0002705948,"domain_scores_codex":[0.9973062,0.0004529032,0.000780393,0.0006270034,0.0001786366,0.0006548481],"domain_scores_gemma":[0.9977006,0.0003139832,0.0006121109,0.0009941116,0.0002389156,0.0001402387],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8820779,0.0003641337,0.1087946,0.00003404778,0.0004111874,0.0000347566,0.00007962878,0.0000443262,0.0004659315,0.000030648,0.007434688,0.0002281896],"study_design_scores_gemma":[0.674815,0.001515566,0.3200765,0.00003049626,0.0002756972,0.000004626725,0.00002580536,0.0001886965,0.0001625606,0.00006309061,0.002710253,0.00013173],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.993044,0.0000761364,0.0005487235,0.001270574,0.0003874557,0.002748975,0.001876914,0.00002367269,0.00002351027],"genre_scores_gemma":[0.9971643,0.0001316933,0.00008686905,0.0004718068,0.0003634354,0.0003690066,0.001320821,0.00003905056,0.00005299874],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2112819,"threshold_uncertainty_score":0.8093287,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01691190991397384,"score_gpt":0.2681455201592174,"score_spread":0.2512336102452436,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}